GLP-1 Pricelist
This page contains affiliate links. We may earn a commission if you sign up through them, at no cost to you. All recommendations are independent.
August 18, 2026 · Price comparison authority

The September 2026 GLP-1 Price Refresh: What Changed From August

August pricing wasn't stable. Several providers pushed promo cycles that ended late in the month, others adjusted maintenance-dose tiers, and manufacturer direct programs quietly nudged their cash-pay rates. Here's the September 2026 snapshot and what moved from August.

The Big Picture

September pricing signals two things. First, the post-Wegovy-pill compounded compression that started in Q2 has stabilized — compounded injectable pricing has landed in a $149-$299 range for most credible providers and is unlikely to compress further without a major regulatory or supply event. Second, manufacturer direct programs (NovoCare, LillyDirect) have held their headline pricing but adjusted intro-period terms in ways that change effective monthly cost.

Reading the September index requires distinguishing between headline monthly price, effective first-year cost including intro periods, and long-term maintenance-dose cost. All three matter differently depending on how long you plan to stay on treatment.

Compounded Injectable Movement

Compounded injectable semaglutide pricing at credible providers has clustered tightly in the $149-$249 range for standard doses. Movement from August to September has been modest — a few providers dropped intro pricing on new-patient promos, a few raised maintenance-dose tiers by $20-$40, and net-net the market average is essentially unchanged.

The exception: providers with $500+ CPA tiers marketed as premium programs have held their pricing without follow-suit compression. That's a deliberate positioning choice, not lag.

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Liv Body

$500 CPA tier

Higher-CPA compounded GLP-1 program.

  • Compounded GLP-1 fulfillment
  • Higher-priced tier
  • Verify current pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Oral Tirzepatide Compression

Oral compounded tirzepatide has settled in a $167-$229 range across the major compounders offering it. Some September promo activity has brought first-month pricing down to $99-$149 briefly at select providers, but maintenance pricing hasn't moved. The oral format's regulatory stability continues to support this segment.

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder — compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Brand-Name Cash-Pay

NovoCare's Wegovy injectable cash rate has held at roughly $199 intro and $349 ongoing. The Wegovy pill format sits at $149-$299 depending on dose. LillyDirect Zepbound vials remain in the $299-$449 range by dose tier. September changes have been minor — some intro period extensions rather than headline rate changes.

Sesame Care

Brand-name Wegovy/Zepbound pathways

Marketplace for brand-name, FDA-approved GLP-1 prescriptions only.

  • Brand-name only (no compounded)
  • Direct-to-patient consult marketplace
  • Cash-pay clarity
Check Latest Pricing

Found Health

$100 off promo — weight loss

Brand-name GLP-1 access with coaching layer.

  • Brand-name focus
  • Coaching + accountability
  • Insurance-coordinated model
Check Latest Pricing

What to Expect in October-November

Historical pattern suggests October and November bring Q4 promo activity — providers push new-patient acquisition ahead of year-end. Expect first-month promos to sharpen, multi-month prepay discounts to appear, and a smaller number of providers to raise maintenance-dose pricing quietly to fund the promotional activity. Read fine print carefully in Q4 — the visible number and the actual annual cost can diverge more than usual.

Telos Rx

Weight-loss LP1 tirzepatide

Compounded tirzepatide via direct pharmacy program.

  • Compounded tirzepatide focus
  • Direct-link intake format
  • Verify current pricing at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Oak Weight Loss

GLP-1 program

Telehealth program with compounded GLP-1 access.

  • Compounded semaglutide/tirzepatide
  • Standard telehealth intake
  • Membership-style pricing
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Where to Start

Embody

Injectable semaglutide (verify current tier)

Lead compounded-injectable option with a $400 CPA tier.

  • Injectable semaglutide only
  • Standard titration schedule
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

Wellorithm

Sema ~$147/mo, tirz ~$249/mo

Compounded GLP-1 with dose-tier pricing.

  • Sema and tirz options
  • Tier pricing by dose
  • Verify at intake
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing

MadeMed

Oral tirzepatide ~$229/mo

Independent compounder — compounded oral tirzepatide.

  • Compounded oral tirzepatide
  • $167–$229 range by dose tier
  • Direct pharmacy fulfillment
FDA note: Compounded GLP-1 medications are not FDA-approved. Personalization must be based on a documented clinical need per current FDA guidance.
Check Latest Pricing
Medical & editorial disclaimer. This article is for informational purposes only and is not medical advice. GLP-1 medications require prescriber evaluation. Compounded GLP-1 medications are not FDA-approved. Talk to a licensed clinician before starting, stopping, or changing any prescription. Provider pricing, availability, and program terms change frequently — verify current details on each provider's site before making a decision. Some links are affiliate links, which means we may earn a commission if you sign up; this does not change our recommendations or the price you pay.